Steward Partners Investment Advisory, LLC Iovance Biotherapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 10,579 shares of IOVA stock, worth $18,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,579
Previous 18,679
43.36%
Holding current value
$18,301
Previous $138,000
74.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IOVA
# of Institutions
337Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$48.1 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$42.2 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$36.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$22 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$19.1 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $273M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...